Nuacht

Jazz Pharmaceuticals misses estimates, slashes guidance on litigation costs
Jazz attributed the earnings miss primarily to a $172 million expense related to Xyrem antitrust litigation settlements. This impacted GAAP and non-GAAP results by $146.3 million after tax, or $2.34 ...
MasterBrand shares tumble on earnings miss, weak guidance
Looking ahead, MasterBrand provided full-year 2025 guidance that fell short of analyst expectations. The company forecasts adjusted EPS of $1.03-$1.32, below the $1.35 consensus. It also expects a low ...
Ultragenyx misses Q1 estimates, shares fall on weak results
Ultragenyx reported a net loss of $151 million for the quarter, or $1.57 per share, compared to a loss of $171 million, or $2.03 per share, in the same period last year. The company ended the quarter ...
Astera Labs stock falls as Q2 guidance fails to impress
The company reported strong demand for PCIe scale-up and Ethernet scale-out connectivity solutions in custom ASIC platforms. Astera Labs also highlighted its PCIe 6 connectivity portfolio, which is ...
Kulicke & Soffa misses Q2 estimates, stock tumbles on weak outlook
Despite the weak results, Kulicke & Soffa generated $79.9 million in operating cash flow and repurchased 0.5 million shares for $21.3 million during the quarter. The company ended the period with $581 ...
Varonis Systems beats Q1 estimates, shares rise on strong SaaS growth
Varonis reported Q1 adjusted earnings of $0.00 per share, beating analyst estimates of -$0.02. Revenue for the quarter came in at $136.4 million, surpassing the consensus estimate of $129.92 million ...
Arcutis Biotherapeutics stock falls despite Q1 revenue beat
Investing.com -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported first quarter 2025 financial results that exceeded analyst expectations for revenue, but the stock fell 6.9% following the ...
US says it has busted major fentanyl trafficking network
WASHINGTON (Reuters) - U.S. law enforcement officials said on Tuesday that they had taken down one of the largest fentanyl ...
Cisco unveils quantum network chip, opens research lab
Cisco (NASDAQ: CSCO), a leading technology company, recently announced the unveiling of its Quantum Network Entanglement Chip ...
Trump in no rush for trade deals, wants everyone to "pay to shop" in America
Trump indicated that the U.S. could sign numerous deals immediately but chooses to prioritize the nation’s interests, stating ...
Powell Industries reports strong Q2 earnings, stock dips slightly
Investing.com -- Powell Industries , Inc. (NASDAQ: POWL) reported better-than-expected second quarter earnings for fiscal 2025, with revenue in line with analyst estimates. The stock dipped 1.9% ...
Vera Therapeutics shares fall as Q1 loss exceeds estimates
Investing.com -- Vera Therapeutics , Inc. (NASDAQ: VERA) reported a wider-than-expected loss for the first quarter of 2025, sending its shares down 2.9% in after-hours trading.